On October 8, 2025, Swissmedic issued an immediate recall for specified batches of ASS Cardio Spirig…
Category: Regulatory Affairs
Global updates on medical device regulation and quality.
Swissmedic Updates Guidelines on Professional Advertising at Events with Patient Representatives
Swissmedic has announced a significant update regarding professional advertising practices during medical education events, particularly those…
Safety Update: Key Field Notices Issued in Early October 2025
Between 29 September and 3 October 2025, critical updates were released regarding medical device safety compliance.…
Swissmedic Advisory: Safety Update for Tegretol 2% Oral Suspension Containing Propylene Glycol
Swissmedic has issued an important safety advisory regarding Tegretol 2% oral suspension, which contains propylene glycol.…
Swissmedic Issues Recall of Maprelin Veterinary Injection for Pigs: Key Details for Healthcare Teams
On October 7, 2025, Swissmedic announced a recall of specific batches of the veterinary medicinal product…
Swissmedic Announces Immediate Recall of Multiple Gonavet Veyx Veterinary Medicine Batches
Swissmedic has issued an urgent recall of several batches of the veterinary medicine Gonavet Veyx ad…
BD BodyComm™ Update: Critical Transition Guidance for Infusion Pumps Ahead of Windows 11 Migration
On October 6, 2025, an important update concerning BD BodyComm™ software was announced. Designed to manage…
Swissmedic September Journal: Key Updates for Regulatory and Quality Teams
Swissmedic, Switzerland’s authority for therapeutic products, has released its latest journal for September 2025. The publication…
GHWP Announces Voluntary Exit from IMDRF Membership
On June 24, 2025, the Global Harmonization Working Party (GHWP) officially stepped down as a member…
Swissmedic Highlights New Adverse Effect for Neptra Veterinary Eardrops
Swissmedic has issued an important update regarding Neptra eardrops for veterinary use in dogs, emphasizing a…